ClinConnect ClinConnect Logo
Search / Trial NCT05407636

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Launched by ABBVIE · Jun 2, 2022

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Age Related Macular Degeneration Neovascular Age Related Macular Degeneration Wet Macular Degeneration Choroidal Neovascularization Retinal Degeneration Retinal Diseases Eye Diseases Ranibizumab Aflibercept Angiogenesis Inhibitors Angiogenesis Modulating Agents Growth Substances Physiological Effects Of Drugs Growth Inhibitors Antineoplastic Agents Gene Therapy Anti Vascular Endothelial Grown Factory Therapy Anti Vegf Therapy Macular Degeneration

ClinConnect Summary

The Pivotal 2 Study is investigating a new gene therapy called ABBV-RGX-314 for people with wet age-related macular degeneration (wet AMD). This condition causes vision loss due to the growth of abnormal, leaky blood vessels in the eye. Currently, patients receive frequent injections every few months to help maintain their vision, which can be burdensome. This trial aims to see if a one-time treatment with RGX-314 can effectively improve or maintain vision in patients affected by wet AMD.

To participate in the study, individuals must be between 50 and 89 years old and have already shown some improvement from previous anti-VEGF treatments. They should also have had cataract surgery at least 12 weeks prior. Participants will receive the gene therapy and will be monitored to see how well it works. This study is currently recruiting participants, and anyone interested should discuss the potential benefits and risks with their healthcare provider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥ 50 years and ≤ 89 years
  • 2. An ETDRS BCVA letter score between ≤ 78 and ≥ 40 in the study eye
  • 3. Diagnosis of subfoveal choroidal neovascularization (CNV) secondary to AMD in the study eye previously treated with anti-VEGF
  • 4. Must be pseudophakic (at least 12 weeks postcataract surgery) in the study eye
  • 5. Willing and able to provide written, signed informed consent for this study
  • 6. Participants must have demonstrated a meaningful response to anti-VEGF therapy at study entry
  • Inclusion Criteria (Bilateral Treatment Substudy)\*:
  • 1. An ETDRS BCVA letter score between ≤ 83 and ≥ 40 in both eyes
  • 2. Diagnosis of subfoveal choroidal neovascularization (CNV) secondary to AMD in both eyes
  • 3. Must be pseudophakic (at least 12 weeks postcataract surgery) in both eyes
  • 4. Willing and able to provide written, signed informed consent for this study
  • 5. Newcomers must have active disease in the study eye; crossover participants must have active disease in the eye not treated in the main study
  • Exclusion Criteria:
  • 1. CNV or macular edema in the study eye secondary to any causes other than AMD
  • 2. Subfoveal fibrosis or atrophy in the study eye
  • 3. Any condition in the investigator's opinion that could limit VA improvement in the study eye
  • 4. Active or history of retinal detachment, or current retinal tear that cannot be treated, in the study eye
  • 5. Advanced glaucoma or history of secondary glaucoma in the study eye
  • 6. Myocardial infarction, cerebrovascular accident, or transient ischemic attack within the past 6 months
  • 7. History of intraocular surgery in the study eye within 12 weeks prior to randomization
  • 8. History of intravitreal therapy in the study eye, such as intravitreal steroid injection or investigational product, other than anti-VEGF therapy, in the 6 months prior to Screening Visit 1
  • 9. Prior treatment with gene therapy
  • Exclusion Criteria (Bilateral Treatment Substudy)\*:
  • 1. CNV or macular edema in either eye secondary to any causes other than AMD
  • 2. Subfoveal fibrosis or atrophy in either eye
  • 3. Any condition in the investigator's opinion that could limit VA improvement in either eye
  • 4. Active or history of retinal detachment, or current retinal tear that cannot be treated in either eye
  • 5. Advanced glaucoma or history of secondary glaucoma in either eye
  • 6. Myocardial infarction, cerebrovascular accident, or transient ischemic attack within the past 6 months
  • 7. History of intraocular surgery in either eye within 12 weeks prior to randomization
  • 8. History of intravitreal therapy in either eye, such as intravitreal steroid injection or investigational product, other than anti-VEGF therapy, in the 6 months prior to screening
  • 9. Prior treatment with gene therapy (\*) For previously treated crossover participants, criteria apply to the eye not treated in the main study only.
  • Note: Other inclusion/exclusion criteria apply

About Abbvie

AbbVie is a global biopharmaceutical company dedicated to developing innovative therapies that address complex health challenges. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie focuses on key therapeutic areas, including immunology, oncology, neuroscience, and virology. The company is committed to advancing scientific research and delivering groundbreaking treatments that enhance patient outcomes and quality of life. With a robust pipeline and a strong emphasis on collaboration, AbbVie strives to transform the future of medicine through its commitment to clinical excellence and patient-centered approaches.

Locations

Rochester, Minnesota, United States

Philadelphia, Pennsylvania, United States

Dallas, Texas, United States

Philadelphia, Pennsylvania, United States

Baltimore, Maryland, United States

Boston, Massachusetts, United States

Pittsburgh, Pennsylvania, United States

Cleveland, Ohio, United States

Nashville, Tennessee, United States

Toronto, Ontario, Canada

Salt Lake City, Utah, United States

Ottawa, Ontario, Canada

Sacramento, California, United States

Baltimore, Maryland, United States

Fort Myers, Florida, United States

Winter Haven, Florida, United States

Rapid City, South Dakota, United States

Beverly Hills, California, United States

Baltimore, Maryland, United States

Cincinnati, Ohio, United States

Walnut Creek, California, United States

Arlington, Texas, United States

Silverdale, Washington, United States

Springfield, Illinois, United States

Santa Ana, California, United States

Lakeland, Florida, United States

New Albany, Indiana, United States

Phoenix, Arizona, United States

Bakersfield, California, United States

Campbell, California, United States

London, , United Kingdom

Tokyo, , Japan

Oak Park, Illinois, United States

Indianapolis, Indiana, United States

Edmonton, Alberta, Canada

West Des Moines, Iowa, United States

Spokane, Washington, United States

La Jolla, California, United States

Philadelphia, Pennsylvania, United States

Pensacola, Florida, United States

Plantation, Florida, United States

Cleveland, Ohio, United States

Encino, California, United States

Reno, Nevada, United States

Richmond, Virginia, United States

Fullerton, California, United States

Poway, California, United States

Rochester, New York, United States

'Aiea, Hawaii, United States

Chattanooga, Tennessee, United States

Calgary, Alberta, Canada

Durham, North Carolina, United States

Oak Forest, Illinois, United States

Salt Lake City, Utah, United States

Marietta, Georgia, United States

Portland, Maine, United States

Chesterfield, Missouri, United States

Bellevue, Washington, United States

Lynchburg, Virginia, United States

Oxford, Oxfordshire, United Kingdom

Longmont, Colorado, United States

Saint Petersburg, Florida, United States

Phoenix, Arizona, United States

Germantown, Tennessee, United States

Phoenix, Arizona, United States

Bellaire, Texas, United States

Norfolk, Virginia, United States

Cleveland, Ohio, United States

Kagoshima, , Japan

Orlando, Florida, United States

Hagerstown, Maryland, United States

Austin, Texas, United States

Abilene, Texas, United States

Boston, Massachusetts, United States

Debrecen, Hajdu Bihar, Hungary

Deerfield Beach, Florida, United States

Créteil, , France

Miyazaki, , Japan

Hickory, North Carolina, United States

Arecibo, , Puerto Rico

San Antonio, Texas, United States

Saint Louis, Missouri, United States

Bloomfield, New Jersey, United States

Durango, Colorado, United States

Riverside, California, United States

Pompano Beach, Florida, United States

Cleveland, Ohio, United States

Lakewood, Colorado, United States

Austin, Texas, United States

North York, Ontario, Canada

Austin, Texas, United States

Fort Worth, Texas, United States

Budapest, , Hungary

Gainesville, Florida, United States

Silverdale, Washington, United States

Liverpool, Merseyside, United Kingdom

San Antonio, Texas, United States

Oak Forest, Illinois, United States

Encino, California, United States

Santa Ana, California, United States

Colorado Springs, Colorado, United States

Gainesville, Florida, United States

Lemont, Illinois, United States

New Albany, Indiana, United States

Cincinnati, Ohio, United States

Edmond, Oklahoma, United States

Salt Lake City, Utah, United States

Ottawa, Ontario, Canada

Bellevue, Washington, United States

Chicago, Illinois, United States

Durango, Colorado, United States

'Aiea, Hawaii, United States

Novi, Michigan, United States

Edina, Minnesota, United States

Memphis, Tennessee, United States

Norfolk, Virginia, United States

Grand Blanc, Michigan, United States

San Antonio, Texas, United States

Jackson, Mississippi, United States

Southlake, Texas, United States

Round Rock, Texas, United States

Lenexa, Kansas, United States

Mesa, Arizona, United States

Sacramento, California, United States

Colorado Springs, Colorado, United States

Gainesville, Florida, United States

Lemont, Illinois, United States

Hagerstown, Maryland, United States

Boston, Massachusetts, United States

Novi, Michigan, United States

Edina, Minnesota, United States

New York, New York, United States

Asheville, North Carolina, United States

Hickory, North Carolina, United States

Columbus, Ohio, United States

Edmond, Oklahoma, United States

Beaufort, South Carolina, United States

Charleston, South Carolina, United States

Florence, South Carolina, United States

Ladson, South Carolina, United States

Johnson City, Tennessee, United States

Nashville, Tennessee, United States

Abilene, Texas, United States

Burleson, Texas, United States

Edmonton, Alberta, Canada

Québec, , Canada

Dallas, Texas, United States

London, , United Kingdom

Paris, , France

Scottsdale, Arizona, United States

La Jolla, California, United States

Palo Alto, California, United States

Torrance, California, United States

Carmel, Indiana, United States

Baltimore, Maryland, United States

Baltimore, Maryland, United States

Royal Oak, Michigan, United States

Minneapolis, Minnesota, United States

Columbia, Missouri, United States

Pittsburgh, Pennsylvania, United States

Beaufort, South Carolina, United States

Charleston, South Carolina, United States

Ladson, South Carolina, United States

San Antonio, Texas, United States

San Antonio, Texas, United States

Salem, Virginia, United States

Vancouver, British Columbia, Canada

Nantes, Loire Atlantique, France

Montauban, Midi Pyrenees, France

Lyon, Rhone, France

Créteil, Val De Marne, France

Paris, , France

Freiburg Im Breisgau, Baden Wurttemberg, Germany

Bonn, Nordhein Westfalen, Germany

Cona, Ferrara, Italy

Roma, Rom, Italy

Roma, , Italy

Kobe, Hyogo, Japan

Córdoba, Cordoba, Spain

Québec, Quebec, Canada

Phoenix, Arizona, United States

Phoenix, Arizona, United States

Scottsdale, Arizona, United States

Bakersfield, California, United States

Beverly Hills, California, United States

Campbell, California, United States

Encino, California, United States

Fullerton, California, United States

La Jolla, California, United States

Oxnard, California, United States

Palo Alto, California, United States

Poway, California, United States

Riverside, California, United States

Sacramento, California, United States

Sacramento, California, United States

Santa Ana, California, United States

Torrance, California, United States

Walnut Creek, California, United States

Colorado Springs, Colorado, United States

Durango, Colorado, United States

Lakewood, Colorado, United States

Longmont, Colorado, United States

Manchester, Connecticut, United States

Deerfield Beach, Florida, United States

Fort Myers, Florida, United States

Gainesville, Florida, United States

Lakeland, Florida, United States

Orlando, Florida, United States

Pensacola, Florida, United States

Plantation, Florida, United States

Saint Petersburg, Florida, United States

Winter Haven, Florida, United States

Marietta, Georgia, United States

'Aiea, Hawaii, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

Lemont, Illinois, United States

Oak Forest, Illinois, United States

Springfield, Illinois, United States

Indianapolis, Indiana, United States

New Albany, Indiana, United States

West Des Moines, Iowa, United States

Lenexa, Kansas, United States

Portland, Maine, United States

Baltimore, Maryland, United States

Baltimore, Maryland, United States

Hagerstown, Maryland, United States

Boston, Massachusetts, United States

Boston, Massachusetts, United States

Worcester, Massachusetts, United States

Grand Blanc, Michigan, United States

Royal Oak, Michigan, United States

Edina, Minnesota, United States

Rochester, Minnesota, United States

Madison, Mississippi, United States

Chesterfield, Missouri, United States

Columbia, Missouri, United States

Saint Louis, Missouri, United States

Reno, Nevada, United States

Bloomfield, New Jersey, United States

Little Silver, New Jersey, United States

New York, New York, United States

Rochester, New York, United States

Asheville, North Carolina, United States

Durham, North Carolina, United States

Hickory, North Carolina, United States

Blue Ash, Ohio, United States

Cleveland, Ohio, United States

Cleveland, Ohio, United States

Columbus, Ohio, United States

Dublin, Ohio, United States

Edmond, Oklahoma, United States

Philadelphia, Pennsylvania, United States

Philadelphia, Pennsylvania, United States

Pittsburgh, Pennsylvania, United States

Beaufort, South Carolina, United States

Charleston, South Carolina, United States

Charleston, South Carolina, United States

Florence, South Carolina, United States

Rapid City, South Dakota, United States

Chattanooga, Tennessee, United States

Germantown, Tennessee, United States

Johnson City, Tennessee, United States

Nashville, Tennessee, United States

Nashville, Tennessee, United States

Abilene, Texas, United States

Austin, Texas, United States

Austin, Texas, United States

Bellaire, Texas, United States

Burleson, Texas, United States

Dallas, Texas, United States

Fort Worth, Texas, United States

Round Rock, Texas, United States

San Antonio, Texas, United States

San Antonio, Texas, United States

San Antonio, Texas, United States

Southlake, Texas, United States

Murray, Utah, United States

Salt Lake City, Utah, United States

Lynchburg, Virginia, United States

Norfolk, Virginia, United States

Richmond, Virginia, United States

Roanoke, Virginia, United States

Bellevue, Washington, United States

Silverdale, Washington, United States

Spokane, Washington, United States

La Crosse, Wisconsin, United States

Calgary, Alberta, Canada

Edmonton, Alberta, Canada

New Westminster, British Columbia, Canada

Vancouver, British Columbia, Canada

Etobicoke, Ontario, Canada

Ottawa, Ontario, Canada

Ottawa, Ontario, Canada

Toronto, Ontario, Canada

Toronto, Ontario, Canada

Quebec City, Quebec, Canada

Nice Cedex 1, Alpes Maritimes, France

Dijon, Cote D Or, France

Toulouse, Occitanie, France

Paris Cedex 14, Paris, France

Nantes, Pays De La Loire, France

Marseille, Provence Alpes Cote D Azur, France

Lyon, Rhone Alpes, France

Creteil, Val De Marne, France

Montauban Cedex, , France

Paris, , France

Freiburg, Baden Wuerttemberg, Germany

Ulm, Baden Wuerttemberg, Germany

Bonn, Nordrhein Westfalen, Germany

Muenster, Nordrhein Westfalen, Germany

Ludwigshafen Am Rhein, Rheinland Pfalz, Germany

Hamburg, , Germany

Puettlingen, , Germany

Debrecen, Hajdu Bihar, Hungary

Budapest, , Hungary

Pécs, , Hungary

Cona, Ferrara, Italy

Milan, Milano, Italy

Milan, Milano, Italy

Naples, Napoli, Italy

Rome, Roma, Italy

Rome, Roma, Italy

Negrar, Verona, Italy

Bari, , Italy

Chieti, , Italy

Udine, , Italy

Nagoya Shi, Aichi, Japan

Fukushima Shi, Fukushima, Japan

Kobe Shi, Hyogo, Japan

Nishinomiya Shi, Hyogo, Japan

Kagoshima Shi, Kagoshima, Japan

Kyoto Shi, Kyoto, Japan

Miyazaki Shi, Miyazaki, Japan

Otsu, Shiga, Japan

Bunkyo Ku, Tokyo, Japan

Arecibo, , Puerto Rico

Santiago De Compostela, A Coruna, Spain

L'hospitalet De Llobregat, Barcelona, Spain

Córdoba, Cordoba, Spain

Las Palmas De Gran Canaria, Las Palmas, Spain

Majadahonda, Madrid, Spain

Barcelona, , Spain

Barcelona, , Spain

Barcelona, , Spain

Madrid, , Spain

Madrid, , Spain

Aylesbury, Buckinghamshire, United Kingdom

London, England, United Kingdom

Gloucester, Gloucestershire, United Kingdom

London, Greater London, United Kingdom

London, Greater London, United Kingdom

Southampton, Hampshire, United Kingdom

Oxford, Oxfordshire, United Kingdom

Leeds, West Yorkshire, United Kingdom

Bradford, , United Kingdom

Bristol, , United Kingdom

Liverpool, , United Kingdom

Manchester, , United Kingdom

Newcastle Upon Tyne, , United Kingdom

Sunderland, , United Kingdom

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials